Letters
Universal health coverage and drug quality
Universal health coverage: drug quality and affordability can go together
BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l6004 (Published 15 October 2019) Cite this as: BMJ 2019;367:l6004
- Raffaella Ravinetto, senior researcher1,
- Catherine Dujardin, health officer2
- 1Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerp, Belgium
- 2Belgian Directorate-General Development Cooperation and Humanitarian Aid, Brussels, Belgium
- rravinetto{at}itg.be
In her thoughtful essay, Elizabeth Pisani warns against some possible unwanted consequences of the efforts to achieve universal health coverage.1 In particular, an unconditional push for the lowest possible prices of essential drugs may lead some manufacturers to apply cuts to quality assurance costs, thus increasing the risk of poor quality drugs or of manufacturers’ withdrawal from the market.1
The …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.